A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease
Public ClinicalTrials.gov record NCT05496374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Investigator-Blinded, Placebo-Controlled, Multicenter, Phase 2, Dose-Ranging Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate 1. The microbiological response and clinical efficacy of SPR720 compared with placebo in participants with nontuberculous mycobacteria pulmonary disease (NTM-PD). 2. The safety and tolerability of SPR720 in participants with NTM- PD 3. The pharmacokinetic (PK) of SPR719, active moiety, following orally (po) administered prodrug SPR720 in participants with NTM-PD.
Study identification
- NCT ID
- NCT05496374
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 25 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 14, 2022 (Actual)
- Primary completion
- Oct 8, 2024 (Actual)
- Completion
- Dec 2, 2024 (Actual)
- Last update posted
- Oct 9, 2025
2022 – 2024
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Facility | Birmingham | Alabama | 35233 | — |
| Medical Facility | Fresno | California | 93701 | — |
| Medical Facility | Los Angeles | California | 90033 | — |
| Medical Facility | Newport Beach | California | 92663 | — |
| Medical Facility | Northridge | California | 91324 | — |
| Medical Facility | Santa Clarita | California | 91355 | — |
| Medical Facility | Washington D.C. | District of Columbia | 20007 | — |
| Medical Facility | Kissimmee | Florida | 34746-4654 | — |
| Medical Facility | Loxahatchee Groves | Florida | 33470 | — |
| Medical Facility | Miami | Florida | 33136 | — |
| Medical Facility | Sebring | Florida | 33870 | — |
| Medical Facility | Tampa | Florida | 33606 | — |
| Medical facility | Atlanta | Georgia | 30342 | — |
| Medical Facility | Iowa City | Iowa | 52242 | — |
| Medical Facility | Kansas City | Kansas | 66103 | — |
| Medical Facility | New Bedford | Massachusetts | 02740 | — |
| Medical Facility | Rochester | Minnesota | 55905 | — |
| Medical Facility | Lebanon | New Hampshire | 03756 | — |
| Medical Facility | New Hyde Park | New York | 11042 | — |
| Medical Facility | Chapel Hill | North Carolina | 27599 | — |
| Medical Facility | Winston-Salem | North Carolina | 27103 | — |
| Medical Facility | Cleveland | Ohio | 44106 | — |
| Medical Facility | Portland | Oregon | 97239 | — |
| Medical Facility | Pittsburgh | Pennsylvania | 15213 | — |
| Medical Facility | Charleston | South Carolina | 29425 | — |
| Medical Facility | Denison | Texas | 75020 | — |
| Medical Facility | Sherman | Texas | 75090 | — |
| Medical Facility | Tyler | Texas | 75708 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05496374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05496374 live on ClinicalTrials.gov.